GGrantIndex
← Leaderboards

Carlos A. Bolanos

Rosalind Franklin Univ Of Medicine & Sci

$3,009,207
Attributed
$3,860,712
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $351.1K · FY200523
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$3,860,712 · 5

By mechanism

R01$3,283,799 · 2
R21$373,733 · 1
F32$130,180 · 1
R03$73,000 · 1

Top collaborators

Most similar at Rosalind Franklin Univ Of Medicine & Sci

Same institution · by research overlap

Others in their field

Top investigators on “Exposure To

Research focus

Exposure ToBrainChildPreferenceNucleus AccumbensRattusBehavioralAdolescentBehaviorMediatingViral VectorAnxietyCocaineAntidepressive AgentsPharmaceutical PreparationsComorbidityPhenotypeMale AdolescentsGenesMental DepressionMental DisordersBiochemicalAdultBehavior Test

Grant awards (17)

Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure$337,634
R01 · FY2023 · DA
Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure$337,869
R01 · FY2022 · DA
Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure$338,093
R01 · FY2021 · DA
Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure$338,306
R01 · FY2020 · DA
Serotonin receptors that potentiate addiction-related behavioral and molecular effects induced by methylphenidate plus SSRI exposure$351,108
R01 · FY2019 · DA
Ontogeny of Drug Exposure and Mood Dysregulation.$342,615
R01 · FY2014 · DA · contact PI
Ontogeny of Drug Exposure and Mood Dysregulation.$292,200
R01 · FY2013 · DA · contact PI
Ontogeny of Drug Exposure and Mood Dysregulation.$29,504
R01 · FY2013 · DA · contact PI
Ontogeny of Drug Exposure and Mood Dysregulation.$305,497
R01 · FY2012 · DA · contact PI
Ontogeny of Drug Exposure and Mood Dysregulation.$300,364
R01 · FY2011 · DA · contact PI
Ontogeny of Drug Exposure and Mood Dysregulation.$310,609
R01 · FY2010 · DA · contact PI
Ontogeny of Physical versus Emotional Stress and Reward Pathways$237,780
R21 · FY2009 · DA · contact PI
Ontogeny of Physical versus Emotional Stress and Reward Pathways$135,953
R21 · FY2008 · DA · contact PI
Adolescent Antidepressant Treatment and Drug Reward$73,000
R03 · FY2005 · DA
NEUROTROPHIC FACTORS SIGNALING AND DRUGS OF ABUSE$48,928
F32 · FY2004 · DA
NEUROTROPHIC FACTORS SIGNALING AND DRUGS OF ABUSE$46,420
F32 · FY2003 · DA
NEUROTROPHIC FACTORS SIGNALING AND DRUGS OF ABUSE$34,832
F32 · FY2001 · DA